Neurobiology of Opioid Dependence: 2 - 2

Phase 2

Withdrawn

• Conditions: Opioid-Related Disorders

• Registration Number: NCT00000193
• Lead Sponsor: Yale University

Brief Summary

The purpose of this study is to evaluate the effects of gamma hydroxybutyric on naloxone-precipitated opiate withdrawal.

Detailed Description

Not available

Study Timeline

• Study Start: 1993-01
• Primary Completion: 1998-01
• Study Completion: 1998-01
• Study First Submitted: 1999-09-20
• Study First Submitted QC: 1999-09-20
• Study First Posted: 1999-09-21
• Status Verified: 2015-08
• Last Update Submitted: 2015-08-05
• Last Update Posted: 2015-08-07

Recruitment & Eligibility

• Status: WITHDRAWN
• Sex: Male
• Target Recruitment: Not specified

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Behavioral, subjective, measures of naloxone-preci
Phsyiological, neuroendocrine measures of naloxone

Trial Locations

Locations (1)

VA Connecticut Healthcare System; 🇺🇸 New Haven, Connecticut, United States